Bram Wagner is an Investor Engagement Officer at the Access to Medicine Foundation. He manages the relationship between the Foundation and institutional investors. This includes the Foundation’s ongoing engagement with healthcare analysts and ESG professionals, to improve their knowledge of how pharmaceutical companies manage risks and opportunities related to access to medicine.
Bram is a pharmacist by training, and holds a Master’s degree in Pharmacy from Utrecht University School of Pharmacy. He also holds the CFA Institute Certificate in ESG Investing. He completed his Master’s thesis at the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation, where he contributed to the analysis of the robustness of an adapted Sustainable Development Goal indicator 3.b.3., which measures access to medicine for children.